These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2761491

  • 1. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
    Keeler R.
    Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491
    [Abstract] [Full Text] [Related]

  • 2. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
    Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio ME, Chávez MT, Calleja C, Tapia E, del Carmen Uribe M, Romero L, Peña JC.
    Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
    [Abstract] [Full Text] [Related]

  • 3. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B, Moreira-Rodrigues M, Serrão P, Pestana M.
    Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
    Pedraza-Chaverrí J, Cruz C, Chávez MT, Ibarra-Rubio ME, Tapia E, Peña JC.
    Rev Invest Clin; 1990 Feb; 42(3):210-6. PubMed ID: 2270368
    [Abstract] [Full Text] [Related]

  • 5. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome.
    Audigé A, Yu ZR, Frey BM, Uehlinger DE, Frey FJ, Vogt B.
    Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683
    [Abstract] [Full Text] [Related]

  • 6. Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
    Kikuchi M, Fujimoto S, Fukae H, Kinoshita H, Kita T, Nakazato M, Eto T.
    J Am Soc Nephrol; 2005 Feb; 16(2):392-7. PubMed ID: 15590761
    [Abstract] [Full Text] [Related]

  • 7. Chemical renal medullectomy and experimental hypertension.
    Russell GI, Bing RF, Taverner D, Swales JD, Thurston H.
    Proc Eur Dial Transplant Assoc; 1983 Feb; 20():546-50. PubMed ID: 6581483
    [Abstract] [Full Text] [Related]

  • 8. Effects of uroguanylin on natriuresis in experimental nephrotic rats.
    Baba A, Fujimoto S, Kikuchi M, Kita T, Kitamura K.
    Nephrology (Carlton); 2009 Feb; 14(1):80-5. PubMed ID: 19054333
    [Abstract] [Full Text] [Related]

  • 9. Effects of low protein diet in puromycin aminonucleoside-induced nephrotic rats.
    Shibasaki T, Gomi H, Ishimoto F, Sakai O.
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):871-5. PubMed ID: 2250404
    [Abstract] [Full Text] [Related]

  • 10. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
    Pedraza-Chaverrí J, Cruz C, Chávez MT, López A, Ibarra-Rubio ME, Tapia E, Peña JC.
    Rev Invest Clin; 1990 Aug; 42(2):120-6. PubMed ID: 2267444
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the effectiveness of sairei-to on puromycin aminonucleoside nephrosis in rats.
    Joarder ZH, Ogawa T, Yorioka N, Yamakido M.
    Hiroshima J Med Sci; 1991 Dec; 40(4):127-35. PubMed ID: 1797743
    [Abstract] [Full Text] [Related]

  • 13. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
    Palluk R, Veress AT, Sonnenberg H.
    Pharmacology; 1989 Dec; 38(4):214-25. PubMed ID: 2526952
    [Abstract] [Full Text] [Related]

  • 14. Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome.
    de Seigneux S, Kim SW, Hemmingsen SC, Frøkiaer J, Nielsen S.
    Am J Physiol Renal Physiol; 2006 Jul; 291(1):F208-17. PubMed ID: 16403831
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J, Nakajima K, Ohno Y, Kaneshiro Y, Matsuo T, Tanaka H, Kaneko K.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):239-44. PubMed ID: 18541230
    [Abstract] [Full Text] [Related]

  • 17. Fluid volumes and hemodynamics in hypertension produced by chemical renal medullectomy.
    Taverner D, Bing RF, Swales JD, Thurston H.
    Am J Physiol; 1985 Aug 28; 249(2 Pt 2):H415-20. PubMed ID: 3895983
    [Abstract] [Full Text] [Related]

  • 18. Reduced renal medullary water channel expression in puromycin aminonucleoside--induced nephrotic syndrome.
    Apostol E, Ecelbarger CA, Terris J, Bradford AD, Andrews P, Knepper MA.
    J Am Soc Nephrol; 1997 Jan 28; 8(1):15-24. PubMed ID: 9013444
    [Abstract] [Full Text] [Related]

  • 19. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
    Bistrup C, Thiesson HC, Jensen BL, Skøtt O.
    Acta Physiol Scand; 2005 Jun 28; 184(2):161-9. PubMed ID: 15916676
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.